The small protein LINC01547-ORF inhibits colorectal cancer progression by regulating the CLDN18-FAK-AKT axis

Shuai Zhang1, Siguang Xu1, Dandan Li2

  • 1Department of Pathology, School of Basic Medical Sciences, Xinxiang Medical University Xinxiang 453003, Henan, China.

PubMed

Insights

A newly identified small protein, LINC01547-ORF, encoded by a long non-coding RNA (lncRNA), significantly inhibits colorectal cancer cell proliferation and migration by targeting CLDN18 and the FAK/PI3K/AKT pathway.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • Long non-coding RNAs (lncRNAs) can encode small proteins with functional roles.
  • Colorectal cancer (CRC) pathogenesis involves complex molecular mechanisms.
  • Identifying novel therapeutic targets in CRC is crucial.

Purpose of the Study:

  • To identify and characterize novel lncRNA-encoded small proteins in colorectal cancer.
  • To investigate the functional role of LINC01547 and its encoded protein (LINC01547-ORF) in CRC.
  • To elucidate the molecular mechanism underlying LINC01547-ORF's anti-cancer effects.

Main Methods:

  • Ribosome profiling to screen for ribosome-associated lncRNAs.
  • Real-time quantitative fluorescence, western blot, and immunofluorescence assays for expression and confirmation.
  • Cellular functional assays (proliferation and migration) and gene set enrichment analysis.
  • Protein molecular docking, co-immunoprecipitation to study protein interactions and signaling pathways (FAK/PI3K/AKT).

Main Results:

  • LINC01547 was identified and confirmed to encode the 76-amino acid protein LINC01547-ORF.
  • LINC01547 expression was downregulated in CRC tissues, but its expression inhibited CRC cell proliferation and migration.
  • LINC01547-ORF directly inhibited CRC cell proliferation and migration, interacting with CLDN18, reducing its ubiquitination, and suppressing the FAK/PI3K/AKT pathway.

Conclusions:

  • The lncRNA-encoded small protein LINC01547-ORF acts as a tumor suppressor in colorectal cancer.
  • LINC01547-ORF inhibits CRC progression by modulating the CLDN18 protein and the FAK/PI3K/AKT signaling pathway.
  • LINC01547-ORF represents a potential therapeutic target for colorectal cancer treatment.

Related Concept Videos

Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K